Phase 1b/2 Trial Of Tepotinib In Sorafenib Pretreated Advanced Hepatocellular Carcinoma With Met Overexpression (Apr, 10.1038/S41416-021-01334-9, 2021)
BRITISH JOURNAL OF CANCER（2021）
Key words
Hepatocellular carcinoma,Molecularly targeted therapy,Biomedicine,general,Cancer Research,Epidemiology,Molecular Medicine,Oncology,Drug Resistance
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined